Co-Authors
This is a "connection" page, showing publications co-authored by Mihai Netea and Karolina Akinosoglou.
Connection Strength
0.174
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
Score: 0.060
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.058
-
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020 06 10; 27(6):992-1000.e3.
Score: 0.055